Efficacy of High Doses of Daptomycin versus Alternative Therapies against Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus

Since the currently approved dose of daptomycin (6 mg/kg of body weight/day) has been associated with clinical failures and resistance development, higher doses for some difficult-to-treat infections are being proposed. We studied the efficacy of daptomycin at high doses (equivalent to 10 mg/kg/day...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Murillo, O., Garrigós, C., Pachón, M. E., Euba, G., Verdaguer, R., Cabellos, C., Cabo, J., Gudiol, F., Ariza, J.
Format: Artigo
Język:Inglês
Wydane: American Society for Microbiology (ASM) 2009
Hasła przedmiotowe:
Experimental Therapeutics
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2764164/
https://ncbi.nlm.nih.gov/pubmed/19635963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00208-09
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy